Novo Nordisk will sell a less expensive one-month supply of Wegovy for patients who previously took compounded versions of ...

Cigna will cap out-of-pocket costs at $200 per month for patients using the weight-loss drugs Wegovy and Zepbound through an ...

The suit comes amid recent studies showing a link between vision complications and people taking drugs containing semaglutide ...

Comedy legend George Wendt has sadly passed away at the age of 76. Known to generations of fans as Norm from Cheers, Wendt's ...

Those who take tirzepatide, the drug sold as Zepbound and Mounjaro, could lose more weight than those who take semaglutide, ...

Cigna’s (NYSE:CI) health services arm, Evernorth, has launched a pharmacy benefit program that caps out-of-pocket costs at ...

The head-to-head examination of these weight loss drugs provides doctors with 'robust' data on their effectiveness.

A new study shows that people Zepbound lost about 50% more weight than those using Wegovy. It was the first head-to-head ...

Pharmaceutical company Novo Nordisk, maker of blockbuster weight loss drug Wegovy, says its CEO is stepping down.

Cigna’s pharmacy benefits unit Evernorth said the deal will bring prices down for employers and their workers.

The lawsuits come amid several recent studies showing a link between vision complications and people taking drugs ...

In a 72-week trial, people taking Zepbound lost 50 pounds on average, compared with about 33 pounds for people taking Wegovy.